EUVIMEDEUVIMED entdecken
Crossref

Evaluating amyloid-beta aggregation and toxicity in transgenic Caenorhabditis elegans models of Alzheimer’s disease

Leticia Priscilla Arantes, Larissa Marafiga Cordeiro, Félix Alexandre Antunes Soares

Methods in Cell Biology · 2025

DOI: 10.1016/bs.mcb.2024.06.001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Methods in Cell Biology, 2025. Verfasst von Leticia Priscilla Arantes und 2 weiteren Autor:innen. Beteiligte Einrichtung: State University of Minas Gerais, Department of Biomedical Sciences and Health, Passos, MG, Brazil. Electronic address: arantes.leticiap@gmail.com. Hauptthemen laut MEDLINE: Caenorhabditis elegans, Alzheimer Disease, Amyloid beta-Peptides, Protein Aggregation, Pathological. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 20 Literaturangaben. Gefördert von: Fundação de Amparo à Pesquisa do Estado de Minas Gerais, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer's disease (AD) is the leading cause of dementia in the elderly, clinically characterized by memory loss, cognitive decline, and behavioral disturbances. Its pathogenesis is not fully comprehended but involves intracellular depositions of amyloid beta peptide (Aβ) and neurofibrillary tangles of hyperphosphorylated tau. Currently, pharmacological interventions solely slow the progression of symptoms. Caenorhabditis elegans (C. elegans) is a simple and valuable organism to study the dynamics of Aβ. It may contribute to advancing our comprehension of AD development and progression, as well as to discovering new treatments. Herein, we describe usual protocols for evaluating Aβ aggregation and toxicity in transgenic C. elegans models of AD (CL2006, CL4176, GMC101, and CL2355 strains) through the visualization and quantification of the peptide with specific fluorescent dyes, in addition to the analysis of particular behaviors (paralysis and chemotaxis associated with learning).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Caenorhabditis elegansAlzheimer DiseaseAmyloid beta-PeptidesProtein Aggregation, PathologicalAnimalsDisease Models, AnimalAnimals, Genetically ModifiedHumansProtein Aggregates

Stichwörter der Autor:innen

AgingAlternative animal modelAmyloid peptideDrug screeningGenetic screeningNeurodegenerative disease

Substanzen

Amyloid beta-PeptidesProtein Aggregates

Autor:innen und Institutionen

  • State University of Minas Gerais, Department of Biomedical Sciences and Health, Passos, MG, Brazil. Electronic address: arantes.leticiap@gmail.com.
  • Federal University of Santa Maria, Center for Natural and Exact Sciences, Department of Biochemistry and Molecular Biology, Graduate Program in Biological Sciences: Toxicological Biochemistry, Camobi, Santa Maria, RS, B…

Förderung

  • Fundação de Amparo à Pesquisa do Estado de Minas Gerais
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Zitieren

APA

Arantes, L. P., Cordeiro, L. M., & Soares, F. A. A. (2025). Evaluating amyloid-beta aggregation and toxicity in transgenic Caenorhabditis elegans models of Alzheimer’s disease. Methods in Cell Biology. https://doi.org/10.1016/bs.mcb.2024.06.001

Vancouver

Arantes LP, Cordeiro LM, Soares FAA. Evaluating amyloid-beta aggregation and toxicity in transgenic Caenorhabditis elegans models of Alzheimer’s disease. Methods in Cell Biology. 2025. doi:10.1016/bs.mcb.2024.06.001

BibTeX
@article{Arantes2025,
  author = {Arantes, Leticia Priscilla and Cordeiro, Larissa Marafiga and Soares, Félix Alexandre Antunes},
  title = {Evaluating amyloid-beta aggregation and toxicity in transgenic Caenorhabditis elegans models of Alzheimer’s disease},
  journal = {Methods in Cell Biology},
  year = {2025},
  doi = {10.1016/bs.mcb.2024.06.001}
}
Kostenlos starten →